NDC 0378-0464
MAXZIDE-25
Maxzide
MAXZIDE-25 is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Hydrochlorothiazide; Triamterene.
| Product ID | 0378-0464_0e54ebec-df86-4205-9434-315913b56a94 |
| NDC | 0378-0464 |
| Product Type | Human Prescription Drug |
| Proprietary Name | MAXZIDE-25 |
| Generic Name | Maxzide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1988-05-13 |
| Marketing End Date | 2024-03-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019129 |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| Active Ingredient Strength | 25 mg/1; mg/1 |
| Pharm Classes | Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS] |
| NDC Exclude Flag | N |